Medline Inc. (MDLN) — Analyst outlook / Analyst consensus target is. Based on 10 analyst ratings, the consensus is bullish — 9 Buy, 1 Hold.
The consensus price target is $48.59 (low: $38.00, high: $56.00), representing an upside of 1.9% from the current price $47.67.
Analysts estimate Earnings Per Share (EPS) of $1.20 and revenue of $28.16B for the next fiscal year.
Earnings Per Share (EPS) track record: 2025: actual $1.43 vs est $1.20 (beat +18.9%). Analyst accuracy: 84%.
MDLN Stock — 12-Month Price Forecast
$48.59
▲ +1.93% Upside
Average Price Target
Based on 10 Wall Street analysts offering 12-month price targets for Medline Inc., the average price target is $48.59, with a high forecast of $56.00, and a low forecast of $38.00.
The average price target represents a +1.93% change from the last price of $47.67.
Highest Price Target
$56.00
Average Price Target
$48.59
Lowest Price Target
$38.00
MDLN Analyst Ratings
Buy
Based on 10 analysts giving stock ratings to Medline Inc. in the past 3 months
EPS Estimates — MDLN
84%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2025
Actual $1.43
vs Est $1.20
▲ 15.9% off
Profitability Outlook
Company is profitable with solid earnings.
Revenue Estimates — MDLN
99%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2025
Actual $28.432B
vs Est $28.157B
▲ 1.0% off
Revenue Trend
Analysts expect stable revenue going forward.
